CCN5通过胸腺酶β4和Cd9途径抑制平滑肌细胞增殖,促进内皮细胞修复,从而抑制损伤性血管再狭窄。

IF 37.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Qi Zhang, Hongda Li, Tao Zhuang, Lehua Xu, Wenrun Wu, Jingjiang Pi, Pengxiong Zhu, Liang Geng, Yunhao Duan, Jianfei Xu, Jinnan Yue, Xiuxiang Liu, Chenlong He, Xiaoli Chen, Chengchao Ruan, Shougang Zhuang, Zhongmin Liu, Yilong Wang, Lin Zhang, Jie Liu, Yuzhen Zhang
{"title":"CCN5通过胸腺酶β4和Cd9途径抑制平滑肌细胞增殖,促进内皮细胞修复,从而抑制损伤性血管再狭窄。","authors":"Qi Zhang, Hongda Li, Tao Zhuang, Lehua Xu, Wenrun Wu, Jingjiang Pi, Pengxiong Zhu, Liang Geng, Yunhao Duan, Jianfei Xu, Jinnan Yue, Xiuxiang Liu, Chenlong He, Xiaoli Chen, Chengchao Ruan, Shougang Zhuang, Zhongmin Liu, Yilong Wang, Lin Zhang, Jie Liu, Yuzhen Zhang","doi":"10.1093/eurheartj/ehae911","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Members of the CCN matricellular protein family are crucial in various biological processes. This study aimed to characterize vascular cell-specific effects of CCN5 on neointimal formation and its role in preventing in-stent restenosis (ISR) after percutaneous coronary intervention (PCI).</p><p><strong>Methods: </strong>Stent-implanted porcine coronary artery RNA-seq and mouse injury-induced femoral artery neointima single-cell RNA sequencing were performed. Plasma CCN5 levels were measured by enzyme-linked immunosorbent assay. Endothelial cell (EC)- and vascular smooth muscle cell (VSMC)-specific CCN5 loss-of-function and gain-of-function mice were generated. Mass spectrometry and co-immunoprecipitation were conducted to identify CCN5 interacting proteins. Additionally, CCN5 recombinant protein (CCN5rp)-coated stents were deployed to evaluate its anti-ISR effects in a porcine model.</p><p><strong>Results: </strong>Plasma CCN5 levels were significantly reduced and correlated closely with the degree of restenosis in ISR patients. CCN5 expression was significantly decreased in VSMCs of stent-implanted porcine coronary segments and injured mouse femoral arteries, especially in synthetic VSMCs. In contrast, elevated CCN5 expression was observed in regenerating ECs of injured vessels. Endothelial cell- and VSMC-specific CCN5 deletion mice exhibited exacerbation of injury-induced neointimal hyperplasia, while CCN5 gain-of-function alleviated neointimal formation. Mechanistic studies identified thymosin β4 (Tβ4) as a CCN5 interacting protein in ECs and EC-CCN5 promoted injury repair through Tβ4 cleavage product Ac-SDKP. Also, CCN5rp promoted EC repair to suppress neointimal hyperplasia via interaction with Cd9 extracellular domain. Moreover, implantation with CCN5rp-coated stent significantly increased stent strut coverage with ECs, which suppressed neointimal formation and ultimately alleviated ISR.</p><p><strong>Conclusions: </strong>CCN5 exerts a dual protective effect on ISR by inhibiting VSMC proliferation and facilitating EC repair. CCN5rp-coated stent might be promising in the prevention of ISR after PCI.</p>","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"1645-1658"},"PeriodicalIF":37.6000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin β4 and Cd9 pathway.\",\"authors\":\"Qi Zhang, Hongda Li, Tao Zhuang, Lehua Xu, Wenrun Wu, Jingjiang Pi, Pengxiong Zhu, Liang Geng, Yunhao Duan, Jianfei Xu, Jinnan Yue, Xiuxiang Liu, Chenlong He, Xiaoli Chen, Chengchao Ruan, Shougang Zhuang, Zhongmin Liu, Yilong Wang, Lin Zhang, Jie Liu, Yuzhen Zhang\",\"doi\":\"10.1093/eurheartj/ehae911\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and aims: </strong>Members of the CCN matricellular protein family are crucial in various biological processes. This study aimed to characterize vascular cell-specific effects of CCN5 on neointimal formation and its role in preventing in-stent restenosis (ISR) after percutaneous coronary intervention (PCI).</p><p><strong>Methods: </strong>Stent-implanted porcine coronary artery RNA-seq and mouse injury-induced femoral artery neointima single-cell RNA sequencing were performed. Plasma CCN5 levels were measured by enzyme-linked immunosorbent assay. Endothelial cell (EC)- and vascular smooth muscle cell (VSMC)-specific CCN5 loss-of-function and gain-of-function mice were generated. Mass spectrometry and co-immunoprecipitation were conducted to identify CCN5 interacting proteins. Additionally, CCN5 recombinant protein (CCN5rp)-coated stents were deployed to evaluate its anti-ISR effects in a porcine model.</p><p><strong>Results: </strong>Plasma CCN5 levels were significantly reduced and correlated closely with the degree of restenosis in ISR patients. CCN5 expression was significantly decreased in VSMCs of stent-implanted porcine coronary segments and injured mouse femoral arteries, especially in synthetic VSMCs. In contrast, elevated CCN5 expression was observed in regenerating ECs of injured vessels. Endothelial cell- and VSMC-specific CCN5 deletion mice exhibited exacerbation of injury-induced neointimal hyperplasia, while CCN5 gain-of-function alleviated neointimal formation. Mechanistic studies identified thymosin β4 (Tβ4) as a CCN5 interacting protein in ECs and EC-CCN5 promoted injury repair through Tβ4 cleavage product Ac-SDKP. Also, CCN5rp promoted EC repair to suppress neointimal hyperplasia via interaction with Cd9 extracellular domain. Moreover, implantation with CCN5rp-coated stent significantly increased stent strut coverage with ECs, which suppressed neointimal formation and ultimately alleviated ISR.</p><p><strong>Conclusions: </strong>CCN5 exerts a dual protective effect on ISR by inhibiting VSMC proliferation and facilitating EC repair. CCN5rp-coated stent might be promising in the prevention of ISR after PCI.</p>\",\"PeriodicalId\":11976,\"journal\":{\"name\":\"European Heart Journal\",\"volume\":\" \",\"pages\":\"1645-1658\"},\"PeriodicalIF\":37.6000,\"publicationDate\":\"2025-05-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Heart Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/eurheartj/ehae911\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurheartj/ehae911","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的:CCN基质细胞蛋白家族成员在各种生物过程中起着至关重要的作用。本研究旨在描述CCN5对血管细胞特异性内膜形成的影响及其在预防经皮冠状动脉介入治疗(PCI)后支架内再狭窄(ISR)中的作用。方法:采用支架植入猪冠状动脉RNA-seq和小鼠股动脉新生内膜单细胞RNA测序。采用酶联免疫吸附法测定血浆CCN5水平。生成内皮细胞(EC)和血管平滑肌细胞(VSMC)特异性CCN5功能丧失和功能获得小鼠。采用质谱法和免疫共沉淀法鉴定CCN5相互作用蛋白。此外,CCN5重组蛋白(CCN5rp)包被支架在猪模型中评估其抗isr作用。结果:ISR患者血浆CCN5水平明显降低,且与再狭窄程度密切相关。CCN5的表达在猪冠状动脉段和损伤小鼠股动脉VSMCs中显著降低,尤其是在合成VSMCs中。相比之下,在损伤血管再生的内皮细胞中观察到CCN5表达升高。内皮细胞和vsmc特异性CCN5缺失小鼠表现出损伤诱导的新内膜增生加剧,而CCN5功能获得减轻了新内膜的形成。机制研究发现胸腺素β4 (t - β4)是ECs中CCN5的相互作用蛋白,EC-CCN5通过t - β4裂解产物Ac-SDKP促进损伤修复。此外,CCN5rp通过与Cd9细胞外结构域相互作用,促进EC修复,抑制内膜增生。此外,ccn5rp涂层支架植入可显著增加内皮细胞覆盖支架支撑,从而抑制内膜形成,最终缓解ISR。结论:CCN5对ISR具有抑制VSMC增殖和促进EC修复的双重保护作用。ccn5rp包被支架在PCI术后ISR的预防中有一定的应用前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin β4 and Cd9 pathway.

Background and aims: Members of the CCN matricellular protein family are crucial in various biological processes. This study aimed to characterize vascular cell-specific effects of CCN5 on neointimal formation and its role in preventing in-stent restenosis (ISR) after percutaneous coronary intervention (PCI).

Methods: Stent-implanted porcine coronary artery RNA-seq and mouse injury-induced femoral artery neointima single-cell RNA sequencing were performed. Plasma CCN5 levels were measured by enzyme-linked immunosorbent assay. Endothelial cell (EC)- and vascular smooth muscle cell (VSMC)-specific CCN5 loss-of-function and gain-of-function mice were generated. Mass spectrometry and co-immunoprecipitation were conducted to identify CCN5 interacting proteins. Additionally, CCN5 recombinant protein (CCN5rp)-coated stents were deployed to evaluate its anti-ISR effects in a porcine model.

Results: Plasma CCN5 levels were significantly reduced and correlated closely with the degree of restenosis in ISR patients. CCN5 expression was significantly decreased in VSMCs of stent-implanted porcine coronary segments and injured mouse femoral arteries, especially in synthetic VSMCs. In contrast, elevated CCN5 expression was observed in regenerating ECs of injured vessels. Endothelial cell- and VSMC-specific CCN5 deletion mice exhibited exacerbation of injury-induced neointimal hyperplasia, while CCN5 gain-of-function alleviated neointimal formation. Mechanistic studies identified thymosin β4 (Tβ4) as a CCN5 interacting protein in ECs and EC-CCN5 promoted injury repair through Tβ4 cleavage product Ac-SDKP. Also, CCN5rp promoted EC repair to suppress neointimal hyperplasia via interaction with Cd9 extracellular domain. Moreover, implantation with CCN5rp-coated stent significantly increased stent strut coverage with ECs, which suppressed neointimal formation and ultimately alleviated ISR.

Conclusions: CCN5 exerts a dual protective effect on ISR by inhibiting VSMC proliferation and facilitating EC repair. CCN5rp-coated stent might be promising in the prevention of ISR after PCI.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Heart Journal
European Heart Journal 医学-心血管系统
CiteScore
39.30
自引率
6.90%
发文量
3942
审稿时长
1 months
期刊介绍: The European Heart Journal is a renowned international journal that focuses on cardiovascular medicine. It is published weekly and is the official journal of the European Society of Cardiology. This peer-reviewed journal is committed to publishing high-quality clinical and scientific material pertaining to all aspects of cardiovascular medicine. It covers a diverse range of topics including research findings, technical evaluations, and reviews. Moreover, the journal serves as a platform for the exchange of information and discussions on various aspects of cardiovascular medicine, including educational matters. In addition to original papers on cardiovascular medicine and surgery, the European Heart Journal also presents reviews, clinical perspectives, ESC Guidelines, and editorial articles that highlight recent advancements in cardiology. Additionally, the journal actively encourages readers to share their thoughts and opinions through correspondence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信